Adam Townsend
2020
In 2020, Adam Townsend earned a total compensation of $2.9M as Chief Commercial Officer at Apellis Pharmaceuticals.
Compensation breakdown
| Bonus | $217,500 |
|---|---|
| Option Awards | $1,828,125 |
| Salary | $430,038 |
| Stock Awards | $415,594 |
| Other | $9,750 |
| Total | $2,901,007 |
Townsend received $1.8M in option awards, accounting for 63% of the total pay in 2020.
Townsend also received $217.5K in bonus, $430K in salary, $415.6K in stock awards and $9.8K in other compensation.
Rankings
In 2020, Adam Townsend's compensation ranked 3,997th out of 13,090 executives tracked by ExecPay. In other words, Townsend earned more than 69.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,997 out of 13,090 | 70th |
Division Manufacturing | 1,608 out of 5,624 | 71st |
Major group Chemicals And Allied Products | 610 out of 2,257 | 73rd |
Industry group Drugs | 526 out of 1,957 | 73rd |
Industry Pharmaceutical Preparations | 400 out of 1,462 | 73rd |
Source: SEC filing on April 22, 2021.
Townsend's colleagues
We found four more compensation records of executives who worked with Adam Townsend at Apellis Pharmaceuticals in 2020.